These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 32428564)
21. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study. Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188 [TBL] [Abstract][Full Text] [Related]
22. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131 [TBL] [Abstract][Full Text] [Related]
23. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression. Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236 [TBL] [Abstract][Full Text] [Related]
24. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14. Guo Y; Liao Y Int Immunopharmacol; 2017 Nov; 52():150-155. PubMed ID: 28910745 [TBL] [Abstract][Full Text] [Related]
26. High serum thioredoxin levels are reduced after tonsillectomy in patients with IgA nephropathy. Nosaki T; Uto H; Takami Y; Oku M; Fukumoto M; Mera K; Nishida C; Tokunaga K; Sogabe A; Oketani M; Ido A; Kurono Y; Tsubouchi H Intern Med; 2012; 51(6):559-65. PubMed ID: 22449662 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy. Liu Y; Liu X; Jia J; Zheng J; Yan T J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815 [TBL] [Abstract][Full Text] [Related]
28. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168 [TBL] [Abstract][Full Text] [Related]
29. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy? Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947 [TBL] [Abstract][Full Text] [Related]
30. Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome. Yang SM; Ka SM; Hua KF; Wu TH; Chuang YP; Lin YW; Yang FL; Wu SH; Yang SS; Lin SH; Chang JM; Chen A Free Radic Biol Med; 2013 Aug; 61():285-97. PubMed ID: 23567192 [TBL] [Abstract][Full Text] [Related]
31. VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and Schönlein-Henoch syndrome: differences between tissue expression and serum concentration. Mrowka C; Heintz B; Sieberth HG Nephron; 1999; 81(3):256-63. PubMed ID: 10050078 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy. Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862 [TBL] [Abstract][Full Text] [Related]
33. First-year GFR slope and long-term renal outcome in IgA nephropathy. Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832 [TBL] [Abstract][Full Text] [Related]
35. Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease. Lundberg S; Lundahl J; Gunnarsson I; Jacobson SH Clin Nephrol; 2010 Mar; 73(3):221-8. PubMed ID: 20178722 [TBL] [Abstract][Full Text] [Related]
36. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy. van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116 [TBL] [Abstract][Full Text] [Related]
37. The renal hemodynamic response to an oral protein load is normal in IgA nephropathy. De Santo NG; Anastasio P; Spitali L; Cirillo M; Santoro D; Pollastro RM; Cirillo E; Capodicasa D; Capasso G Nephron; 1997; 76(4):406-10. PubMed ID: 9274837 [TBL] [Abstract][Full Text] [Related]
38. The role of complement in IgA nephropathy. Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413 [TBL] [Abstract][Full Text] [Related]
39. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy. Li XH; Huang XP; Pan L; Wang CY; Qin J; Nong FW; Luo YZ; Wu Y; Huang YM; Peng X; Yang ZH; Liao YH BMC Nephrol; 2016 Nov; 17(1):164. PubMed ID: 27806690 [TBL] [Abstract][Full Text] [Related]
40. Complement-C1q TNF-Related Protein 3 Alleviates Mesangial Cell Activation and Inflammatory Response Stimulated by Secretory IgA. Zhang R; Zhong L; Zhou J; Peng Y Am J Nephrol; 2016; 43(6):460-8. PubMed ID: 27309491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]